-
-
-
-
-
-
-
TFF Pharmaceuticals Inc. (TFFP) Provides Update on TFF TAC Phase 2 Trial
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Presented Baseline Data from the CAHtalyst Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Announces FDA Acceptance and Priority Review of the BLA for Upstaza
-
-
-
-
-
-
-
Jasper Therapeutics (JSPR) Announces Briquilimab Development Program in Asthma
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Announces Approval of AUGTYRO in China
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT A
-
-
-
-
-
-
-
Revance Therapeutics (RVNC) Expands into US Market with the Launch of DAXXIFY
-
67,067 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.